The Latest Headlines at American Banking and Market News
Stifel Nicolaus Lowers Pine Cliff Energy (TSE:PNE) Price Target to C$1.10
Pine Cliff Energy (TSE:PNE – Get Free Report) had its target price decreased by analysts at Stifel Nicolaus from C$1.20 to C$1.10 in a research report issued on Thursday, BayStreet.CA reports. Stifel Nicolaus’ price objective... More of this article »
Nutrien (TSE:NTR) PT Raised to C$59.00
Nutrien (TSE:NTR – Get Free Report) had its price objective increased by equities research analysts at Mizuho from C$54.00 to C$59.00 in a research report issued to clients and investors on Thursday, BayStreet.CA reports. Mizuho’s... More of this article »
Cormark Analysts Boost Earnings Estimates for goeasy Ltd. (TSE:GSY)
goeasy Ltd. (TSE:GSY – Free Report) – Equities researchers at Cormark raised their Q2 2024 earnings estimates for goeasy in a research note issued on Wednesday, May 8th. Cormark analyst J. Fenwick now expects that the... More of this article »
Intact Financial Co. to Post Q2 2024 Earnings of $3.60 Per Share, Desjardins Forecasts (TSE:IFC)
Intact Financial Co. (TSE:IFC – Free Report) – Stock analysts at Desjardins increased their Q2 2024 earnings per share estimates for Intact Financial in a research note issued on Wednesday, May 8th. Desjardins analyst... More of this article »
Intact Financial Co. (TSE:IFC) Expected to Post Q2 2024 Earnings of $3.80 Per Share
Intact Financial Co. (TSE:IFC – Free Report) – Research analysts at Raymond James increased their Q2 2024 earnings per share estimates for shares of Intact Financial in a research note issued on Wednesday, May 8th.... More of this article »
Q2 2024 EPS Estimates for Elanco Animal Health Incorporated (NYSE:ELAN) Decreased by William Blair
Elanco Animal Health Incorporated (NYSE:ELAN – Free Report) – William Blair dropped their Q2 2024 earnings estimates for Elanco Animal Health in a report released on Wednesday, May 8th. William Blair analyst B. Vazquez... More of this article »
Analysts Offer Predictions for Esperion Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:ESPR)
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Equities researchers at Northland Capmk increased their Q2 2024 earnings estimates for Esperion Therapeutics in a research report issued to clients and investors... More of this article »
L.B. Foster to Post Q2 2024 Earnings of $0.42 Per Share, B. Riley Forecasts (NASDAQ:FSTR)
L.B. Foster (NASDAQ:FSTR – Free Report) – Analysts at B. Riley upped their Q2 2024 earnings per share estimates for shares of L.B. Foster in a research report issued on Thursday, May 9th. B. Riley analyst A. Rygiel... More of this article »
FibroGen, Inc. (NASDAQ:FGEN) Expected to Post Q2 2024 Earnings of ($0.24) Per Share
FibroGen, Inc. (NASDAQ:FGEN – Free Report) – William Blair raised their Q2 2024 earnings per share (EPS) estimates for shares of FibroGen in a research note issued on Tuesday, May 7th. William Blair analyst A. Hsieh... More of this article »
Enlight Renewable Energy Ltd (NASDAQ:ENLT) to Post Q2 2024 Earnings of $0.05 Per Share, Roth Capital Forecasts
Enlight Renewable Energy Ltd (NASDAQ:ENLT – Free Report) – Investment analysts at Roth Capital reduced their Q2 2024 earnings per share (EPS) estimates for shares of Enlight Renewable Energy in a note issued to investors... More of this article »
Seaport Res Ptn Weighs in on FMC Co.’s Q2 2024 Earnings (NYSE:FMC)
FMC Co. (NYSE:FMC – Free Report) – Stock analysts at Seaport Res Ptn dropped their Q2 2024 earnings per share estimates for FMC in a research report issued to clients and investors on Wednesday, May 8th. Seaport Res... More of this article »
Q2 2024 EPS Estimates for Ero Copper Corp. (NYSE:ERO) Increased by National Bank Financial
Ero Copper Corp. (NYSE:ERO – Free Report) – Investment analysts at National Bank Financial lifted their Q2 2024 earnings per share estimates for Ero Copper in a research report issued on Wednesday, May 8th. National... More of this article »
Zacks Research Weighs in on Encompass Health Co.’s Q2 2024 Earnings (NYSE:EHC)
Encompass Health Co. (NYSE:EHC – Free Report) – Stock analysts at Zacks Research dropped their Q2 2024 earnings per share estimates for shares of Encompass Health in a research note issued on Wednesday, May 8th. Zacks... More of this article »